Clinical Trials Logo

Subacute Thyroiditis clinical trials

View clinical trials related to Subacute Thyroiditis.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06285617 Not yet recruiting - Clinical trials for Subacute Thyroiditis

Short-Term Versus 6-Week Prednisone in The Treatment of Subacute Thyroiditis

SAT
Start date: April 1, 2024
Phase: Phase 3
Study type: Interventional

The goal of this clinical trial is to compare the efficacy and safety of short-term versus 6-week prednisone in the treatment of moderate-to-severe subacute thyroiditis. The main questions it aims to answer are: Does the short-term medication regimen reduce glucocorticoid side effects while achieving similar efficacy as the guideline treatment group? Patients with moderate-to-severe symptoms were randomly assigned to receive either 30 mg/day prednisone for 1 week, followed by 1 week of nonsteroidal anti-inflammatory drugs, or the conventional 6-week prednisone therapy in the control group.